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Abstract
Canine distemper is a highly contagious and immunosuppressive viral disease caused by canine distemper virus
(CDV),  an  enveloped  RNA  virus  of  the  family  Paramyxoviridae.  The  susceptible  host  spectrum  of  CDV  is  broad  and
includes all families of the order Carnivora. To accomplish the infection, CDV requires an expression of signaling lymphocyte
activation molecule (SLAM) functioning as a cellular receptor which generally presents in a variety of different lymphoid cell
subpopulations, including immature thymocytes, primary B cells, activated T cells, memory T cells, macrophages and mature
dendritic cells. The distribution of SLAM-presenting cells is in accordance with the lymphotropism and immunosuppression
following morbillivirus infection. In the present study, the C57BL/6 mice engrafted with dog-specific SLAM sequence
(DogSLAM) were used. The weanling (3-week-old) transgenic offspring C57BL/6 mice were infected with CDV Snyder Hill
(CDV-SH) strain via the intranasal (n=6), intracerebral (n=6) and intraperitoneal (n=5) routes. Clinical signs, hematology,
histopathology, immunohistochemistry, virus isolation and RT-PCR were observed for two weeks post infection. Results
showed that CDV-SH-inoculated transgenic mice displayed mild-to-moderate congestion of various organs (brain, lung,
spleen, kidney, lymph node, and adrenal gland). By means of immunohistochemistry, virus isolation and RT-PCR, CDV could
not be detected. The evidence of CDV infection in this study could not be demonstrated in acute phase. Even though the
transgenic mouse is not a suitable animal model for CDV, or a longer incubation period is prerequisite, it needs to be clarified
in a future study.
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1. Introduction
Canine distemper is a highly contagious and immuno-
suppressive disease caused by canine distemper virus (CDV),
a  morbillivirus  of  family  Paramyxoviridae.  The  susceptible
host  spectrum  is  broad  including  all  families  of  the  order
Carnivora; the Canidae (dogs, foxes, dingos), Felidae (cats),
Mustelidae (ferrets, minks, badgers, weasels) and Proconi-
dae (raccoons) (Baumgärtner et al., 2003; Wohlsein et al.,
2007; Beineke et al., 2009). In addition, several cell lines and
primary cells from different species and tissues have been
used for CDV isolation and infection which mimic the in vivo
situation (Appel and Jones, 1967; Baumgartner et al., 1987;
von Messling et al., 2004; Puff et al., 2009). The tropism of
morbillivirus-infectable  cells  has  been  correlated  to  the
presence  of  a  well  known  cellular  receptor  the  so-called
signaling lymphocyte activation molecule (SLAM, CD150).
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SLAM, a membrane glycoprotein, is expressed in a variety
of lymphoid cell subpopulations, which in accordance with
the lymphotropism and immunosuppression following mor-
billivirus infection (Tatsuo et al., 2001; Tatsuo and Yanagi,
2002;  Wenzlow  et  al.,  2007;  Schneider-Schaulies  and
Schneider-Schaulies, 2008).
Currently,  transgenic  mice  are  widely  used  in  bio-
medical research on cancer and neurodegenerative disorders
with increasing evidence that genetic host factors play a key
role in susceptibility (Burgermeister et al., 2000; Jucker et
al., 2000; Guk et al., 2005; Gordon and Bosland, 2009). In
humans,  a  devastating  inflammatory  demyelinating  and
neurodegenerative  diseases  of  the  central  nervous  system
(CNS) is multiple sclerosis (MS), which commonly affects
young adults (Franklin and Ffrench-Constant, 2008; Schrei-
ner et al., 2009). Although the pathogenesis of demyelination
in MS has been intensively studied, the underlying mecha-
nisms are still poorly understood. Therefore, naturally-occur-
ring and experimentally-induced demyelinating animal models
including canine distemper virus (CDV)-infected dogs and
Theiler’s murine encephalomyelitis virus (TMEV)-induced
mice, respectively, are considered promising tools for investi-
gating the pathogenesis of MS (Beineke et al., 2009; Ulrich
et al., 2009).
Various strains of laboratory mice, besides dogs and
ferrets, have been employed as animal models for studying
the pathogenesis of CDV including Swiss albino mice, ddY
mice or SJL mice (Lyons et al., 1980; Bernard et al., 1983;
Hirayama et al., 1986). Recently, CD150 (SLAM) transgenic
C57BL/6 mice have been generated and have displayed a
high susceptibility to measles virus (MV), a closely-related
morbillivirus  to  CDV  (Welstead  et  al.,  2005;  Sellin  et  al.,
2006). Studies using such transgenic models have signifi-
cantly contributed to the understanding of the cellular and
tissue tropism of measles virus infection that may reveal a
new perspective on the implications of SLAM in the neuro-
pathogenicity of other morbilliviruses. In this present study,
we  used  offspring  DogSLAM  transgenic  C57BL/6  mice
generated  by  microinjection  of  the  pCAGDogSLAM  tag
plasmid into the pronuclei of the founder’s fertilized oocytes.
To  further  elucidate  the  susceptibility  to  CDV,  we  investi-
gated the pathological alterations in the following 2-weeks
post infection.
2. Materials and Methods
2.1 Animals
Fifty 3-month-old transgenic C57BL/6 founder mice
(25 males and 25 females) were bought from the Kumamoto
University, Japan. Animals were housed in a specific patho-
gen  free  (SPF)  unit  and  used  for  in-house  breeding  (The
protocol was authorized by DNA committee, Japan). Their
offspring (F1) was tested for the DogSLAM gene using poly-
merase chain reaction (PCR) as previously described with
modifications (Grunenwald, 2003). Briefly, the tail biopsy (1-2
cm, weight ~100-500 mg) from each F1 transgenic mice was
used for genomic DNA extraction by using the phenol : chlo-
roform extraction method followed by a RNase treatment
(Pearson  and  Stirling,  2003).  The  20  l-PCR  reaction  was
carried out using a 2 l DNA, master mixed PCR solution
(Qiagen, Germany) and a pair of specific DogSLAM primers
(Table  1).  pCAGDogSLAMTag  plasmid  was  used  as  a
positive control and the products were visualized on 1.2%
agarose gel.
2.2 Cells and virus
Vero DogSLAMTag (Vero DST) cells were generated
by the transfection of African monkey kidney (Vero) cells
with pCAGDogSLAMTag plasmid as previously described
(Seki et al., 2003). Cells were grown in Dulbecco’s modified
eagle’s medium (DMEM) supplemented with 7% heat inacti-
vated fetal calf serum (FCS), 0.15% sodium carbonate and
0.4 mg/ml G418 until the culture reached 80% confluence. The
culture was washed twice with FCS-free DMEM and incu-
bated with 1 ml CDV Snyder Hill (CDV-SH) strain (dilution 1 :
100; kindly provided by Dr.Summers, the Cornell University,
USA).  Subsequently,  the  infected  culture  was  maintained
under  standard  condition  (37°C,  4%  CO2,  water-saturated
atmosphere) for 60 min and followed by the addition of 9 ml
10% Tryptose Phosphate Broth (TPB) and FCS-free DMEM
for a 24-hr incubation period. The culture was harvested for
CDV-SH  stock  preparation  when  a  90%  cytopathic  effect
(CPE) characterized by syncytial cell formation was observed.
After  centrifugation  (3,000  rpm,  10  min),  the  supernatant
was transferred into a new tube and sonicated for 7 cycles
composed of 30 sec on and 1 min off per cycle (Biorupture
®,
Japan). The virus titration was done and calculated for the
50% log10 tissue culture infectious dose (TCID50). The virus
stock was kept at -80°C until use.
2.3 Experiment design
Twenty 3-week-old DogSLAM-transgenic F1 mice
were divided into four groups and inoculated with 1x10
5
TCID50  of  CDV-SH  through  different  routes  of  infection.
Group I consisted of three mock-infected control mice inocu-
Table 1. List of used primers: sequences, annealing temperatures and the length of amplicons
   Genes                        Forward primers                       Reverse primers Ta (
oC) Amplicon (bp)
DogSLAM 5’-GGTACTGCTGCTCTGGGTTC-3’ 5’-CCTTCATTTTCCCTCCTGCT-3’ 50 427
CDV-NP 5’-ATGTTTATGATCACAGCGGT-3’ 5’-ATTGGGTTGCACCACTTGTC-3’ 50 429539 S. Techangamsuwan et al. / Songklanakarin J. Sci. Technol. 32 (6), 537-546, 2010
lated with DMEM via intranasal (IN), intracerebral (IC) and
intraperitoneal (IP) route, Group II-IV composed of five to
six CDV-SH-infected mice inoculated via IN, IC and IP route
(Table 2). Animals in each group were separately housed and
supplied ad libitum with sterile water and food.
2.4 Clinical observation and hematology
Body weight and clinical signs of CDV-SH-infected
mice including respiratory (oculonasal discharge, pneumo-
nia), gastrointestinal (diarrhea) or nervous system (stagger-
ing gate, lack of coordination) were routinely monitored for
14 days post infection (dpi). Detection of CDV viral inclusion
bodies was performed from the conjunctival swab in every
three days by using Dip Quick
® and Shorr’s staining.
At 14 dpi, the infected mice were sacrificed. Heart
blood  was  collected  for  hemogram  evaluation  which  is
included a total red blood cell count (RBCs), hemoglobin
(Hb), hematocrit (Hct), total white blood cell count (WBCs),
WBC differential count and thrombocyte count. Macroscopic
lesions  of  the  nervous,  respiratory  and  gastrointestinal
systems  were  recorded.  Tissues  from  these  organs  were
collected for detection of CDV by viral isolation, histopatho-
logy, immunohistochemistry and reverse transcriptase poly-
merase chain reaction (RT-PCR).
2.5 CDV isolation
Single cell suspension was prepared from 0.5 g of the
brain,  lung  and  spleen  of  mock-  and  CDV-SH  inoculated
mice. Tissues were mechanically minced and sonicated in 10
ml DMEM. After centrifugation (5,000 rpm, 4°C, 5 min), the
supernatant was collected and the virus was isolated using
Vero DST cells. Subsequently, the cultures were maintained
under standard conditions and daily observed for the CPE
(see above).
2.6 Histopathology
Selected tissues (brain, spinal cord, gastrointestinal
tract, lung, spleen, lymphoid tissue, thymus, kidney, urinary
bladder and prepuce or vagina) were preserved in 10% neutral
buffered formalin. Routine histological processes were done
and the 4-m thick sections were stained with hematoxylin
and eosin (H&E) and Luxol fast blue-cresyl echt violet stain.
Samples were evaluated microscopically under light micro-
scope.
2.7 Immunohistochemistry
For the detection of CDV antigen and DogSLAM
receptor, the selected tissues (see Histopathology) were
immunostained using a labeled streptavidin–biotin (LSAB)
method. Briefly, the 4 m-thick sections were deparaffinized,
autoclaved in phosphate buffer saline (PBS, 121°C, 5 min) for
antigen retrieval and immersed in 0.3% hydrogen peroxide
(H2O2) in methanol (room temperature, 10 min) for non-spe-
cific endogenous peroxidase blocking. After 3 washing steps
with PBS, the monoclonal anti-CDV (dilution 1:10, Monotope
Virostat
®,  USA)  or  anti-HA  antibodies  (dilution  1:200,
Boehringer Mannheim, Germany) were applied for 60 min at
37°C and followed by the biotinylated anti-mouse IgG anti-
bodies  and  envision  polymer  (Envision  Polymer  DAKO
®,
Denmark) for 30 min at 37°C. The reaction was visualized
with 3, 3'-diaminobenzidine tetrahydrochloride (DAB) for
2 min and counterstained with Mayer’s hematoxylin. The
non-infected Vero DST cells and mock-infected mouse brain
were used as negative controls whereas the infected Vero
DST cells and clinically CDV-infected dog’s brain were used
as  positive  controls.  The  percentage  of  positive  cells  was
quantitatively scored under light microscope as (-) negative,
(+1) less than 10% of positive cells, (+2) 10-50% of positive
cells, (+3) more than 50% of positive cells.
2.8 RNA extraction and reverse transcriptase (RT)-PCR
The viral RNA was extracted from the brain, lung,
spleen, and/or peripheral blood mononuclear cells (PBMCs)
by the acid phenol guanidine isothiocyanate method. Briefly,
200-300 l supernatant of homogenized tissues was lysed
with Trizol
® (ratio 1:1, GibcoBRL
™, USA) and incubated at
-80°C  overnight.  Sixty  l  of  phenol : chloroform:isoamyl
alcohol (ratio 25:24:1) was added and mixed well. After cen-
trifugation (13,000 rpm, 15 min, 4°C) the supernatant was
transferred into a new tube and followed by addition of 0.5 l
glycogen (20 mg/ml) and 150 l isopropyl alcohol, respec-
tively. After 15 min incubation and centrifugation (10,000
rpm, 15 min) RNA pellet was washed with 70% ethanol and
dried at room temperature for 20-30 min. Finally, the pellet
was dissolved in deionized water and kept at -20°C until use.
For RT-PCR, the CDV nucleoprotein (CDV-NP) gene
was amplified employing 5 l RNA and a one step RT-PCR
kit  (Invitrogen,  Japan)  according  to  the  manufacturer’s
instructions. The PCR conditions are displayed in Table 1.
CDV-SH  strain  was  used  as  a  positive  control  and  PCR
products were visualized as mentioned above.
2.9 Statistical analysis
Data  was  analyzed  using  the  Statistical  Analysis
System version 9.1 software (SAS Institute, Cary, NC). The
clinical hematology data was expressed as mean and standard
deviation (SD) and compared using a one-way analysis of
variance (ANOVA). P-values of less than 0.05 were consid-
ered to indicate statistically significant differences.
3. Results
3.1 Expression of DogSLAM gene in F1 transgenic mice
The founder transgenic mice that harbored DogSLAM
gene were bred in-house. To ensure the transmission of theS. Techangamsuwan et al. / Songklanakarin J. Sci. Technol. 32 (6), 537-546, 2010 540
DogSLAM transgene to F1 progeny, all offspring were tested
using gene-specific PCR analysis from tail biopsies (Figure
1). The results showed that they displayed the specific band
in  427  base  pairs  (bp)  when  compared  to  the  pCAGDog
SLAMTag plasmid used as a positive control and indicated
the incorporation of DogSLAM gene in their genome.
3.2 Weight,  clinical  observation,  hematology  following
CDV-SH infection
The 3-week-old F1 transgenic mice were divided into
four groups and inoculated with 1x10
5 TCID50 of CDV-SH
through different routes of infection including mock-infect-
ion (Table 2). Mice were clinically observed and daily weighed
for two weeks. The infected mice displayed no clinical signs
in any inoculated group throughout the observation period
when  compared  to  the  controls.  In  addition,  they  did  not
show  significant  weight  loss  after  infection  suggesting  a
normal  appetite  (Table  2).  Moreover,  the  CDV  inclusion
bodies from conjunctival swab were done every 3 days using
Dip Quick
® and Shorr’s stain. No evidence of viral inclusion
bodies  was  observed  at  any  time  point  in  any  inoculated
group (Figure 2).
Clinical hematology was performed at 14 dpi to eva-
luate the status of blood cell component including erythro-
cytes, leukocytes and thrombocytes (Table 3). The number
of erythrocytes (RBC) from intraperitoneal inoculation group
was significantly different from control group (**, p<0.05)
but remained in the normal range. The packed cell volume
or hematocrits (Hct) in all infected groups were increased
when compared to control group. A decrease in thrombocyte
number  (platelets)  was  found  in  all  groups  including  the
control.
3.3 Macroscopic, microscopic and immunohistochemical
study following infection
Mice  were  humanely  euthanized  and  post-mortem
examined  following  14  dpi.  By  macroscopic  investigation,
Figure 1. PCR analysis of DogSLAM gene expression from tail
biopsies  of  F1  transgenic  C57BL/6  mice  indicating  a
specific  band  at  427  base  pairs  (bp).  M:  DNA  ladder
marker, P: positive control (pCAGDogSLAMTag plas-
mid), 1-10: DNA sample from tails of individual F1
transgenic mice.
Figure 2. Detection  of  canine  distemper  virus  (CDV)  inclusion
bodies on conjunctival epithelium every 3 days post in-
fection. They showed no evidence of inclusion bodies
throughout the observation period (A; DipQuick
®, B:
Shorr’s  staining)  when  compared  to  a  positive  eosino-
philic intracytoplasmic inclusion bodies (arrow) derived
from CDV-infected dog (C: Shorr’s staining). Scale bar
~10mm.
Table 2. Body weights of the 3-week-old F1 transgenic mice in control and
canine distemper virus Snyder Hill strain infected groups at 14 days
post infection
                       Group Weight (grams; Mean ± Standard deviation)
I. Control 13.65 ± 2.60
(n = 3)
II. Intranasal inoculation (IN) 14.52 ± 3.07
(n = 6)
III. Intracerebral inoculation (IC) 15.32 ± 3.67
(n = 6)
IV. Intraperitoneal inoculation (IP) 12.45 ± 2.43
(n = 5)
Normal value* 12.3-13.6 ± 1.6
*Normal value of body weight in C57BL/6 mice
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there were no remarkable lesions in any infected group when
compared to the control (data not shown). On the contrary,
the main lesions found at the histopathological level of all
groups  were  pulmonary  hemorrhage,  congestion  and
atelectalsis (Table 4, Figure 3). The intracerebral inoculation
group showed lesions both in the respiratory and lymphatic
system characterized by mild to moderate pulmonary hemor-
rhage,  congestion  and  mild  interstitial  pneumonia  (Figure
3C) as well as lymph node congestion. Moreover, congestion
at the corticomedullary junction of the adrenal gland and
congestion of the brain were noted. In the intraperitoneal
inoculation group, lesions were mainly found in the respira-
tory  system  and  included  pulmonary  atelectalsis,  mild  to
moderate lung hemorrhage and congestion, focal vasculitis
in the lung and increased pulmonary alveolar macrophages
(PAMs) (Figure 3D). Congestion and extramedullary hemato-
poiesis in the spleen and congestion of the kidney were also
noted.
Detection of CDV antigen and SLAM receptor was
done using monoclonal mouse anti-CDV antibodies and anti-
HA antibodies, respectively, by the immunohistochemistry
method. A panel of selected tissues was stained including the
brain, spinal cord, lung, heart, spleen, lymph node, adrenal
gland, liver, pancreas, stomach, small intestine, large intes-
tine, kidney, urinary bladder and vagina/prepuce. Neither the
CDV antigen nor the SLAM receptor was positive in any
group  when  compared  to  the  positive  controls  (data  not
shown).
Table 3. Clinical hematology of F1 transgenic mice in control and canine distemper virus Snyder Hill
(CDV-SH) strain infected groups at 14 days post infection
Control Intranasal Intracerebral Intraperitoneal Normal value*
(n = 3) inoculation inoculation inoculation
(n = 6) (n = 6) (n = 5)
RBC (10
6/L)         6.80±1.93**   8.24±0.63    7.31±1.26         8.47±0.74** 8.3
(6.5-10.1)
Hb (g/dL) 12.05±1.71 13.15±0.57 12.28±1.80 12.50 ±1.30 13.1
(1.1-16.1)
Hct (%)    37.70±11.30 45.01±1.86 40.25±6.68 45.70 ±2.81 40.4
(32.8-48.0)
MCV (fl) 55.15±1.79 54.73±2.50 55.13±1.95 54.04±1.94 49.1
(42.3-55.9)
MCH (pg) 18.85±6.43 15.96±0.70    17.2±4.18 14.74±0.62 15.9
(13.7-18.1)
MCHC (g/dL)    34.55±13.12 29.21±0.59 31.08±6.74 27.28±1.42 32.3
(29.5-35.1)
Platelet (10
4 /L)    0.02±0.01    0.14±0.31    0.04±0.05    0.15±0.09 1.16
(0.78-1.54)
WBC (10
3 /L)     4.35±1.26    4.58±1.95    3.50±1.59    3.80±1.01 6.33
(2.61-10.05)
Neutrophil (%)    0.25±0.10    0.31±0.52     0.14±0.13    0.31±0.07 1.20
(0.4-2.0)
Lymphocyte  (%)    3.92±1.29    4.19±1.96    3.22±1.51    3.33±1.03 4.86
(1.27-8.44)
Monocyte (%)    0.17±0.11    0.06±0.05    0.12±0.07   0.14±0.02 0.14
(0-0.29)
Eosinophil  (%)    0±0 0.008±0.02    0±0   0±0 0.08
(0-0.17)
Basophil (%)    0±0    0±0    0±0   0±0 0
(0-0.02)
Abbreviations:
red blood cell (RBC), hemoglobin (Hb), hematocrit (Hct), mean corpuscular volume (MCV),
mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC),
white blood cell (WBC)
   * Normal value (Pilny, 2008)
** Significant differences between control and CDV-SH-infected mice via intraperitoneal inoculation
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3.4 CDV isolation and RT-PCR study following infection
Viral isolation was done using single cell suspension
from the brain, lung and spleen and inoculated in Vero DST
cells. Following infection, the cultures were monitored daily
for CPE characterized by syncytial cell formation. All isolated
tissues from the CDV-SH-infected groups displayed no CPE
following infection. The cultures remained as a single cellular
layer without CPE (Figure 4B). To confirm the presence of
the  CDV  nucleoprotein  (CDV-NP)  gene  at  the  molecular
level, the selected tissues (brain, lung, spleen, PBMCs) from
infected F1 transgenic mice were monitored by RT-PCR. All
samples were negative when compared to the CDV-SH strain
used as a positive control, which represented a specific band
at 429 bp (Figure 4C).
4. Discussion
The close interaction between the infectivity of mor-
billiviruses and their specific cellular receptor, the signaling
lymphocyte activation molecule (SLAM), of target cells is
well recognized. The expression profile of SLAM distributes
Table 4. Histopathological lesions of various organs following CDV-SH infection in F1 transgenic mice
         Organs/Lesions Control Intranasal Intracerebral Intraperitoneal
(n = 3) inoculation inoculation inoculation
(n = 6) (n = 6) (n = 5)
Brain
· Congestion +1 (1/3) - +1 (1/6) -
Spinal cord - - - -
Lung
· Edema - - +1 (1/6) -
· Congestion - - +1 (3/6) +1 (1/5)
· Hemorrhage +2 (1/3) +1 (1/6),  +2 (1/6) +2 (1/6) +1(1/5); +2 (1/5); +3 (1/5)
· Atelectalsis +1 (1/3) +1 (1/6) +1 (1/6) +1 (2/5)
· Emphysema - - - +1 (1/5)
· Focal  vasculitis - - - +1 (1/5)
· Increased PAM - - - +1 (1/5)
· Interstitial pneumonia - - - -
Heart - - - -
Spleen
· Hemosiderosis - - +1 (1/6) +1(2/5)
· Congestion - - - +2 (1/5)
Lymph node
· Congestion - - +2 (1/6) -
Adrenal gland
· Congestion at CM junction - - +2 (1/6) -
Liver - - - -
Pancreas - - - -
Stomach - - - -
Small intestine - - - -
Large intestine - - - -
Kidney
· Congestion - - +1 (1/6) +1 (1/5)
Urinary bladder - - - -
Vagina/ prepuce - - - -
Abbreviations: pulmonary alveolar macrophage (PAM), corticomedullary (CM)
Lesion score: (-) no remarkable lesion, (+1) mild degree, (+2) moderate degree, (+3) severe degree543 S. Techangamsuwan et al. / Songklanakarin J. Sci. Technol. 32 (6), 537-546, 2010
Figure 3. Histopathological findings of lungs in mock- (A) and canine distemper Snyder Hill (CDV-SH)-infected groups inoculated in
different routes (B: intranasal, C: intracerebral, D: intraperitoneal route). A and B displayed moderate pulmonary hemorrhage (scale
bar ~50 m). C showed mild interstitial pneumonia (scale bar ~25 m) while D elucidated mild degree of increased pulmonary
alveolar macrophages (PAMs; arrows; scale bar ~10 m).
Figure 4. Detection of canine distemper virus (CDV) from infected F1 transgenic C57BL/6 mice using viral isolation on Vero DST cells (A-
B) and RT-PCR (C). Tissue suspension from the brain, lung and spleen displayed no cytopathic effect (CPE, B) when compared
to the CPE of a positive control characterized by syncytial cell formation of Vero DST (A, arrows, scale bar ~100 mm). RT-PCR
analysis of CDV nucleoprotein gene expression from the brain, lung, spleen and  peripheral  blood  mononuclear  cells  (PBMCs)
of infected F1 transgenic mice showed all negative results. M: DNA ladder marker, P: positive control (CDV Snyder Hill strain),
1-12: RNA sample from F1 transgenic mice.
to  a  variety  of  lymphoid  cell  subpopulations  including
immature  thymocytes,  primary  B  cells,  activated  T  cells,
memory T cells, macrophages and mature dendritic cells,
which  is  in  agreement  with  lymphopenia  and  immuno-
suppressive status following measles virus (MV) or CDV
infection (Kruse et al., 2001; Ostrakhovitch and Li, 2006).
However, the mechanism of morbillivirus-induced demyeli-
nation is still fragmentary due to the lack of SLAM-positive
cells in the nervous system (McQuaid and Cosby, 2002). In
addition, a significant number of oligodendrocytes, myelin-
forming cells of the CNS, were not decreased, even in the
chronic  and  completely  demyelinated  distemper  lesions,
suggesting the demyelination precedes oligodendrocyte loss
(Schobesberger et al., 1999; Schobesberger et al., 2002).
The small animal model including mice for morbilli-
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results of using the human SLAM transgenic C57BL/6 mice
infected with MV, the closely related morbillivirus to CDV,
have been revealed a high susceptibility to MV infection via
intranasal route. These transgenic mice have developed the
neurological signs prior to establish the systemic infection
by using CD11c-positive dendritic cells (Shingai et al., 2005;
Welstead et al., 2005; Sellin et al., 2006). These findings
open new perspectives for the analysis of the role of SLAM
in the neuropathogenicity of other morbilliviruses, like CDV,
which also utilize this molecule as a viral receptor. In addi-
tion, these transgenic mice may serve as a useful model for
the investigation of the pathomechanism of CDV-induced
demyelination.
In this present study, the weanling (3-week-old) off-
spring DogSLAM transgenic C57BL/6 mice were generated
and infected with the CDV Snyder Hill (CDV-SH) strain via
intranasal, intracerebral and intraperitoneal routes. The ino-
culated  transgenic  mice  showed  no  evidence  of  CDV-SH
infection  regardless  of  the  route  of  virus  administration
which were evaluated from clinical signs, hematology, histo-
pathological alteration as well as antigen detection by immu-
nohistochemistry, virus isolation and RT-PCR. Contrary to
previous studies, our observations revealed the insensibility
of C57BL/6 mice to the CDV-SH strain even though SLAM
has been integrated into the genome of mice. This implies
two possibilities of negative results. Firstly, CDV infection in
rodents might use other molecules as viral receptors due to
the fact that, so far, there is no entry receptor for CDV that
has been identified in mice. Secondly, there is more than one
molecular receptor that plays a role in the initial process of
CDV entry including CD46 or CD9. The CD46 molecule clari-
fies as a membrane cofactor protein (MCP) or a complement
regulatory  molecule,  which  represents  a  primate-specific
receptor for the laboratory-adapted Edmonston strain of MV
and is expressed on all nucleated cells (Dörig et al., 1993;
Dörig  et  al.,  1994).  The  CD9,  a  tetraspan  transmembrane
protein, is considered an essential factor for CDV uptake by
target cells, cell-cell (but not virus-cell) syncytial cell forma-
tion and the production of progeny virus (Löffler et al., 1997;
Schmid et al., 2000). In addition, it has recently been shown
that p75 neurotrophin receptor (p75
NTR) might play a role in
CDV infection in mixed canine brain and glial cell cultures
(Orlando et al., 2008; Techangamsuwan et al., 2009).
Taken together, the evidence of CDV infection in this
study  could  not  be  demonstrated  in  acute  phase.  Future
investigations have to generate other single or double trans-
genic mice that constitutively express both receptors and to
investigate the susceptibility to CDV infection. Even though
the transgenic mouse is not a suitable animal model for CDV,
or a longer incubation period is prerequisite, it needs to be
clarified.
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